Log In
BCIQ
Print this Print this
 

CDE-001

  Manage Alerts
Collapse Summary General Information
Company VivaCell Biotechnology Espana S.L.
DescriptionCombination of cannabigerol and cannabidiol
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today